Polyxeni Kiousi

476 total citations
19 papers, 395 citations indexed

About

Polyxeni Kiousi is a scholar working on Endocrinology, Diabetes and Metabolism, Spectroscopy and Animal Science and Zoology. According to data from OpenAlex, Polyxeni Kiousi has authored 19 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Spectroscopy and 6 papers in Animal Science and Zoology. Recurrent topics in Polyxeni Kiousi's work include Hormonal and reproductive studies (16 papers), Mass Spectrometry Techniques and Applications (8 papers) and Muscle metabolism and nutrition (5 papers). Polyxeni Kiousi is often cited by papers focused on Hormonal and reproductive studies (16 papers), Mass Spectrometry Techniques and Applications (8 papers) and Muscle metabolism and nutrition (5 papers). Polyxeni Kiousi collaborates with scholars based in Greece, Qatar and Cyprus. Polyxeni Kiousi's co-authors include Yiannis S. Angelis, Costas Georgakopoulos, Argyro G. Fragkaki, Nassia Kioukia‐Fougia, G. Tsoupras, Ariadni Vonaparti, E. Lyris, Irene Panderi, Michel W. F. Nielen and P. Sakellariou and has published in prestigious journals such as Analytica Chimica Acta, Rapid Communications in Mass Spectrometry and Journal of Mass Spectrometry.

In The Last Decade

Polyxeni Kiousi

19 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Polyxeni Kiousi Greece 11 258 133 114 91 76 19 395
Michaël Polet Belgium 15 312 1.2× 157 1.2× 139 1.2× 117 1.3× 72 0.9× 29 430
Wim Van Gansbeke Belgium 15 356 1.4× 166 1.2× 167 1.5× 122 1.3× 97 1.3× 23 492
Cristiana Colamonici Italy 12 222 0.9× 169 1.3× 154 1.4× 95 1.0× 68 0.9× 23 456
E. Lyris Greece 10 180 0.7× 148 1.1× 83 0.7× 53 0.6× 104 1.4× 13 356
Francesco Molaioni Italy 11 214 0.8× 100 0.8× 92 0.8× 90 1.0× 36 0.5× 20 364
James Scarth United Kingdom 14 320 1.2× 80 0.6× 161 1.4× 119 1.3× 94 1.2× 36 535
Danielle Goudreault Canada 9 266 1.0× 75 0.6× 105 0.9× 106 1.2× 52 0.7× 11 360
Pieter Van Renterghem Belgium 14 444 1.7× 110 0.8× 176 1.5× 171 1.9× 86 1.1× 18 502
Laura Tretzel Germany 9 230 0.9× 77 0.6× 65 0.6× 91 1.0× 20 0.3× 12 363
N. Desmet Belgium 8 152 0.6× 54 0.4× 92 0.8× 74 0.8× 56 0.7× 13 341

Countries citing papers authored by Polyxeni Kiousi

Since Specialization
Citations

This map shows the geographic impact of Polyxeni Kiousi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Polyxeni Kiousi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Polyxeni Kiousi more than expected).

Fields of papers citing papers by Polyxeni Kiousi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Polyxeni Kiousi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Polyxeni Kiousi. The network helps show where Polyxeni Kiousi may publish in the future.

Co-authorship network of co-authors of Polyxeni Kiousi

This figure shows the co-authorship network connecting the top 25 collaborators of Polyxeni Kiousi. A scholar is included among the top collaborators of Polyxeni Kiousi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Polyxeni Kiousi. Polyxeni Kiousi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Angelis, Yiannis S., et al.. (2023). LC‐MS/(MS) confirmatory doping control analysis of intact phase II metabolites of methenolone and mesterolone after Girard's Reagent T derivatization. Drug Testing and Analysis. 15(6). 654–667. 4 indexed citations
2.
Angelis, Yiannis S., Argyro G. Fragkaki, Polyxeni Kiousi, et al.. (2023). New long‐standing metabolites of 17α‐methyltestosterone are detected in HepG2 cell in vitro metabolic model and in human urine. Drug Testing and Analysis. 16(6). 604–615. 5 indexed citations
3.
Kiousi, Polyxeni, Argyro G. Fragkaki, Nassia Kioukia‐Fougia, & Yiannis S. Angelis. (2021). Liquid chromatography–mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes. Drug Testing and Analysis. 13(11-12). 1822–1834. 12 indexed citations
4.
Sakellariou, P., Michael Petrou, Argyro G. Fragkaki, et al.. (2021). Determination of salmeterol, α‐hydroxysalmeterol and fluticasone propionate in human urine and plasma for doping control using UHPLC–QTOF–MS. Biomedical Chromatography. 35(8). e5114–e5114. 3 indexed citations
5.
Sakellariou, P., Polyxeni Kiousi, Argyro G. Fragkaki, et al.. (2020). Alternative markers for Methylnortestosterone misuse in human urine. Drug Testing and Analysis. 12(11-12). 1544–1553. 5 indexed citations
6.
Fragkaki, Argyro G., Polyxeni Kiousi, Nassia Kioukia‐Fougia, et al.. (2020). Determination of anabolic androgenic steroids as imidazole carbamate derivatives in human urine using liquid chromatography–tandem mass spectrometry. Journal of Separation Science. 43(11). 2154–2161. 11 indexed citations
7.
Fragkaki, Argyro G., P. Sakellariou, Polyxeni Kiousi, et al.. (2018). Human in vivo metabolism study of LGD‐4033. Drug Testing and Analysis. 10(11-12). 1635–1645. 38 indexed citations
8.
Angelis, Yiannis S., et al.. (2018). Discrimination of tetryl samples by gas chromatography – Isotope ratio mass spectrometry. Forensic Chemistry. 12. 42–45. 5 indexed citations
9.
Fragkaki, Argyro G., et al.. (2017). Challenges in detecting substances for equine anti‐doping. Drug Testing and Analysis. 9(9). 1291–1303. 23 indexed citations
10.
Kiousi, Polyxeni, et al.. (2015). Current Status and Recent Advantages in Derivatization Procedures in Human Doping Control. Bioanalysis. 7(19). 2537–2556. 6 indexed citations
11.
Fragkaki, Argyro G., Yiannis S. Angelis, Polyxeni Kiousi, Costas Georgakopoulos, & E. Lyris. (2015). Comparison of sulfo‐conjugated and gluco‐conjugated urinary metabolites for detection of methenolone misuse in doping control by LC‐HRMS, GC‐MS and GC‐HRMS. Journal of Mass Spectrometry. 50(5). 740–748. 37 indexed citations
12.
Kiousi, Polyxeni, Yiannis S. Angelis, Argyro G. Fragkaki, et al.. (2015). Markers of mesterolone abuse in sulfate fraction for doping control in human urine. Journal of Mass Spectrometry. 50(12). 1409–1419. 17 indexed citations
13.
Kioukia‐Fougia, Nassia, et al.. (2013). A Synopsis of the Adverse Analytical and Atypical Findings Between 2005 and 2011 from the Doping Control Laboratory of Athens in Greece. Journal of Analytical Toxicology. 38(1). 16–23. 2 indexed citations
14.
15.
Kiousi, Polyxeni, Yiannis S. Angelis, E. Lyris, et al.. (2009). Two-Step Silylation Procedure for The Unified Analysis of 190 Doping Control Substances in Human Urine Samples by GC–MS. Bioanalysis. 1(7). 1209–1224. 12 indexed citations
16.
Georgakopoulos, Costas, Ariadni Vonaparti, Polyxeni Kiousi, et al.. (2007). Preventive doping control analysis: liquid and gas chromatography time‐of‐flight mass spectrometry for detection of designer steroids. Rapid Communications in Mass Spectrometry. 21(15). 2439–2446. 91 indexed citations
17.
18.
Kioukia‐Fougia, Nassia, et al.. (2005). An overview of the doping control analysis during the Olympic Games of 2004 in Athens, Greece. Analytica Chimica Acta. 555(1). 1–13. 40 indexed citations
19.
Kiousi, Polyxeni, et al.. (2004). Gas Chromatographic ? Mass Spectrometric Cardiotonic Glycosides Detection in Equine Urine Doping Analysis. Chromatographia. 59(S1). S105–S108. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michaël Polet Breakdown of academic impact, for papers by Wim Van Gansbeke Breakdown of academic impact, for papers by Cristiana Colamonici Breakdown of academic impact, for papers by E. Lyris Breakdown of academic impact, for papers by Francesco Molaioni Breakdown of academic impact, for papers by James Scarth Breakdown of academic impact, for papers by Danielle Goudreault Breakdown of academic impact, for papers by Pieter Van Renterghem Breakdown of academic impact, for papers by Laura Tretzel Breakdown of academic impact, for papers by N. Desmet
Rankless by CCL
2026